书名 痴呆病学
  丛书多卷书否 N
  ISBN 7-5308-4175-0
  主要责任者 何伋,李浒,路英智等;丁福忠,马明辉,亓仲儒等
  责任方式 主编;副主编
  出版者 天津科学技术出版社
  出版地 天津
  出版日期 2006-10
  装帧
  页码 1-419
  字数 380
  开本 32
  定价 32.00
  作品语种
  整书中图分类号 R749.1
  参考文献 [1]何伋,张作记,杜翠瑛,等.老年脑科学.北京:北京出版社,2001.
[2]何伋,张立华,张世豪,等.临床综合征辞典.海口:南海出版公司,1997.
[3]何伋,马恩轩,成义仁,等.神经精神病学辞典.北京:中国中医药出版社,1998.
[4]何伋,马恩轩,成义仁,等.内科疾病神经精神症状与精神障碍.济南:山东科学技术出版社,1994.
[5]何伋,马恩轩,成义仁,主编.儿童神经精神病学.天津:天津科学技术出版社,1995.
[6]何伋,路英智,刘同顺,等.精神病学.北京:中国中医药出版社,1998.
[7]何伋,李浒,亓仲儒,等.神经精神综合征学.海口:南海出版公司,2005.
[8]高素荣,袁锦楣.痴呆诊断学.北京:北京科学技术出版社,1998.
[9]盛树力.老年性痴呆:从分子生物学到临床诊治.北京:科技文献出版社,1998:118-123.
[10]陈万生,徐江平,李立,等.大黄素-8-O-β-D-吡喃葡萄糖苷的促智活性及其机制.中草药,2001,32(1):39-41.
[11]张世仪,陈艳,左萍,等.746-3对Alzheimer's病样大鼠的治疗作用.基础医学与临床,2001,21(1):69-72.
[12]马怡,徐秋萍.中药抗老年期痴呆的实验药理研究简况.中国实验方剂学杂志,1997,3(1):34-37.
[13]张晓东,李万亥,枉前,等.人参皂甙Rgl,Re对β-淀粉样蛋白诱导原代培养海马及皮层神经元损失的保护作用.第二军医大学学报,2000,21(10):941-943.
[14]江黎明,李志明,韩宝铭.神经生长因子活性中草药及其成分的筛选.中草药,1994,25(2):79.
[15]尹兆宝,王健,吴洪梅,等.调神方对实验性AD痴呆大鼠记忆行为和血清细胞因子含量的影响.上海中医药大学学报,2000,14(3):42-44.
[16] Steingart A,Hachinski VC,Lau C,et al.Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan.Arch Neurol,1987,44:32-5.
[17] Goto K.,Ishii N,Fukosawa H.Diffuse white-matter disease in the geriatric population:A clinical,neuropathological and CT study.Neuro-Radiology,1981,141:687-695.
[18]贾西津.老年期痴呆与抑郁的流行病学及方法学.中国心理卫生志,1999,13(2):94-96.
[19] Andersen K,Nielsen H,Lolk A,et al.Incidence of very mild to severe dementia and Alzheimer's disease in Denmark:The Odense Study.Neurology,1999,52(1):85-90.
[20] Shyu YI,Yip PK.Factor structure and explanatory variable of the Mini-Mental State Examination (MMSE) for elderly persons in Taiwan.J Formos Med Assoc,2001,100(10):676-683.
[21] Helkala EL,Kivipelto M,Hallikainen M,et al.Usefulness of repeated presentation of Mini-Mental State Examination as a diagnostic procedure:A population-based study.Acta Neurol Scand,2002,106(6):341-346.
[22] Fisher CM,Adams RD.Transient global amnesia.Trans Am Neurol Assoc,1958,83:143.
[23] Fisher CM,Adams RD.Transient global amnesia.Trans Am Neural Scand,1964,49(suppl):1.
[24] Rockwood K,Stadnyk K.The prevalence of dementia in the elderly:A review.Can J Psychiatry,1994,39(6):253-257.
[25] J Corey-Bloom,LJ Thal,D Galasko,et al.Diagnosis and evaluation of dementia.Neurology,1995,45:211-218.
[26] Schofield PW,Tang MX,Marder K,et al.Consistency of clinical diagnosis in a community-based longitudinal study of dementia and Alzheimer's disease.Neurology,1995,45:2159-2164.
[27] Launer LJ,Masaki K,Petrovitch H,et al.The association between mildlife blood pressure levels and late life cognitive function.JAMA,1995,274:1846-1851.
[28] Pantoni L,Carosi M,Amigoni S,et al.A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis.Clin Neuropharmacol,1996,19(6):497-506.
[29] Rother M,Erkinjuntti T,Roessner M,et al. Propentofylline in the treatment of Alzheimer's disease and vascular dementia:A review of phase Ⅲ trials.Dement Geriatr Cogn Disord,1998,9(suppl 1):36-43.
[30] Roman GC,Tatemichi TK,ErkinjunttiT,et al.Vascular dementia:Diagnostic criteria for reaserch studies.Neurology,1993,43:250.
[31] Scheinberg P.Dementia due to vascular disease:a multifactorial disease.Stroke,1998,19:1291.
[32] Takemichi TK.How acute brain failure becomes chronic:A view of the mechanisms of dementia related to strike. Neurology,1990,40:1652.
[33] World Health Organization(WHO).The neurological adaptation of the International Classification of Disease(ICD-10NA).Geneva:World Health Organization,1991.
[34] Chui HC,Victoroff JI,Margolin D,et al.Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's Disease Diagnostic and Treamment Centers.Neurology,1992,42:473.
[35] Lippa CF,Ozawa k,Mann DMA,et al.Deposition of β-amyloid subtypes 40 and 42 differentiates dementia with Lewy bodies from Alzheimer disease.Arch Neurol,1999,56:1111.
[36] Schneider JA,Gearing M,Robbins RS,et al.Apolipoprotein E genotype in diverse neurodegenerative diaorder.Ann Neurol,1995,38:131.
[37] Saitoh t,Xia Y,Chen X,et al.The CYP2D6B mutant allele is over represented in the Lewy body variant of Alzheimer's diaease.Ann Neurol,1995,37:110.
[38] Mckeith I,O'Brien J.Dementia with Lewy bodies.Aust N Z J Psychiatry,1999,33:800.
[39] Barber R,Panikkar A,Mckeith IG.Dementia with Lewy bodies:diagnosis and management.Int J Geriatr Psychiatry,2001,16(suppl 1):S12-18.
[40] Zhou L,Miller BL,McDaniel CH,et al.Frontotemporal dementia:neuropil spheroids and presynaptic terminal degeneration.Ann Neurol,1998,44:99-109.
[41] Stenens M,Van Duijn CM,Kamphorst w,et al.Familial aggregation in frontotemoral dementia.Neurology,1998,50:1541-1545.
[42] Mendez MF,Cherrier M,Perryman K M,et al. Frontotemporal dementia versus Alzheimer's disease:differential cognitive features. Neurology,1996,47:1189-1194.
[43] Hooten WM,Lyketsos CG. Frontotemporal dementia:a clincopathological review of four postmortem studies.J Neuropsychiatry Clin Neurosci,1996,8:10-19.
[44] Stevens T,Livingston G,Kitchen G,et al.Study of dementia subtypes in the community.Br J Psychiatry,2002,180:270-276.
[45] Okazaki H,Lipton LS,Aronson SM.Diffuse intracytoplasmatic ganglionic inclusions(lewy type) associated with progressive dementia and quadripesis in flexion.J Neuropath Exp Neurol,1961,20:237-244.
[46] Jellinger KA.Neuropathological spectrum of synucleinopathies.Mov Disord,2003,18(suppl 6):s2-12.
[47] Lang-Rollin I,Rideout H,Stefanis L.Ubiquitinated inclusions and neuronal cell death.Histol Histopathol,2003,18(2):509-517.
[48] Mckeith IG,Galasko D,Kosaka K,et al.Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies(DLB):report of the consortium on DLB international workshop.Neurology,1996,47:1113-1124.
[49] Palmer EP.Transient global amnesia and the amnestic syndrome.Med Clin North Am,1986,70:1361.
[50] Ciang DW.Transient global amnesia associated with cerebral angiography performed with use of Iopamidol.Radiology,1989:172-195.
[51] Rowan AJ.Transient global amnesia:clincial and electroencephalographic findings in 10cases.Neurology,1979,29:869.
[52] Pasquier F,Petit H.Frontotemporal dementia:its rediscovery.Eur NEUROL,1997,38:1-6.
[53] Zhou L,Miller BL,McDaniel CH,et al.Frontotemporal dementia:neuropil spheroids and presynaptic terminal degeneration.Ann Neurol,1998,44:99-109.
[54] Stenens M,Van Duijn CM,Kaphorst W,et al.Familial aggregation in frontotemporal dementia.Neurology,1998,50:1541-1545.
[55] Mendez MF,Cherrier M,Perryman KM,et al. Frontotemporal dementia versus Alzheimer's diaease: differential cognitive features.Neurology,1996,47:1189-1194.
[56] Nagafuchi S,Yanagisawa H,Sato K,et al.Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromoso me 12p.Nature Genet,1994,6:14-18.
[57] Smith JK,Gonda VE,Malamud N.Unusual form of cerebellar ataxia:Combined dentatorubral and pallidoluysian degeneration.Neurology,1958,8:205-207.
[58] Smith JK.Dentatorubral Pallidoluysian atropby.In:Vinken PJ,Bruyn GW,eds.Handbook of Clinical Neurology,Vol 21.Amsterdam:North-Hollang Pabco,1975:519-522.
[59] Dewan MJ,Gupta S.Toward a definite diagnosis of Alzheimer's disease.Comprehensive Psychiatry,1992,33:282.
[60] Whitehouse PJ,Price DL,Struble RG,et al.Alzheimer's disease and senile dimentia:loss of neurons in the bassal forebrain.Science,1982,215:1237.
[61] Sellati TJ,Wilkinspn DA,Sheffield JS,et al.Virulent treponema pallidum,lipoprotein,and synthetic lipopetieds induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency vius typel.J Infect Dis,2000,181(1):283-293.
[62] Greene SR,Stamm LV.Molecular characterization of Treponema pallidum mcp2,a putative chemotaxis protein gene.Infect Immunm,1998,66(6):2999-3002.
[63] Kawai W,Baba A,Mizukami K,et al.CT,MR,SPECT findings in a generalparesis.Computer Med Imaging Graph,1994,18(6):461-465.
[64] Stamm NE,Handsfield HH,Rompalo AM,et al.The assocition between genital ulcer disease and acquisition of HIV infection in homosexual men.JAMA,1988,260(10):1429-1433.
  辞典简介 本册工具书共收录45条词条。